ArticleBreast cancer research and treatment2025

Survival impact of adjuvant capecitabine in triple-negative breast cancer Latin American patients with residual disease: a real-world study.

Noiver Graciano et al.PubMed ↗Publisher ↗

No numbers read from the abstract.